FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 240 filers reported holding FATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $415,647 | -83.4% | 41,194 | -63.1% | 0.25% | -82.7% |
| Q3 2022 | $2,500,000 | -15.1% | 111,545 | -6.1% | 1.43% | -19.6% |
| Q2 2022 | $2,943,000 | +17.4% | 118,778 | +83.7% | 1.78% | +11.5% |
| Q1 2022 | $2,507,000 | +85.7% | 64,665 | +180.2% | 1.59% | +48.3% |
| Q4 2021 | $1,350,000 | +32.9% | 23,081 | +34.7% | 1.08% | +60.0% |
| Q3 2021 | $1,016,000 | +5.2% | 17,134 | +54.0% | 0.67% | -1.9% |
| Q2 2021 | $966,000 | +75.0% | 11,128 | -19.4% | 0.68% | +70.4% |
| Q3 2020 | $552,000 | +29.0% | 13,807 | +10.8% | 0.40% | +13.6% |
| Q2 2020 | $428,000 | – | 12,463 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |